◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2297

Rainmed Medical Limited (2297) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-11

Rainmed Medical Limited (2297) operates in the Medical Devices industry and is headquartered in Suzhou, China with about 210 employees. Its market capitalization is roughly CNY 291 million. In the fiscal year ended 2025-12-31, 2297 reported CNY 19M in revenue and (CNY 77M) in net income.

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally.

Interactive charts & full statements →

2297 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 19MCNY 40MCNY 73MCNY 84M
Gross ProfitCNY 9MCNY 24MCNY 49MCNY 70M
Operating Income (EBIT)(CNY 75M)(CNY 100M)(CNY 133M)(CNY 145M)
Net Income(CNY 77M)(CNY 114M)(CNY 116M)(CNY 1.3B)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2297 Free Cash Flow History

2297 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 546MCNY 463MCNY 573MCNY 690M
Total LiabilitiesCNY 188MCNY 53MCNY 53MCNY 72M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2297 viewer.

Other Companies in Medical Devices

← 2296All “0-9” companies2298 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.